Similarly, three out of four mice injected with HMLE-11A cells developed tumours within 8 weeks of injection (Fig. 3d and Supplementary Fig. 4c) suggesting that elevated levels of BCL11A promote tumour development. This evidence concerns the gene BCL11A and neoplasm.